$131.24
4.47% yesterday
Nasdaq, Sep 05, 10:00 pm CET

ICU Medical, Inc. Target price 2025 - Analyst rating & recommendation

ICU Medical, Inc. Classifications & Recommendation:

Buy
83%
Hold
17%

ICU Medical, Inc. Price Target

Target Price $183.60
Price $131.24
Potential
Number of Estimates 7
7 Analysts have issued a price target ICU Medical, Inc. 2026 . The average ICU Medical, Inc. target price is $183.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 10 Analysts recommend ICU Medical, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2026 of . Most analysts recommend the ICU Medical, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.38 2.24
5.44% 6.13%
EBITDA Margin 4.36% 17.63%
51.41% 303.96%
Net Margin -4.94% 7.87%
276.32% 259.29%

9 Analysts have issued a sales forecast ICU Medical, Inc. 2025 . The average ICU Medical, Inc. sales estimate is

$2.2b
Unlock
. This is
5.75% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.3b 0.99%
Unlock
, the lowest is
$2.1b 10.60%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.4b 5.44%
2025
$2.2b 6.13%
Unlock
2026
$2.2b 1.30%
Unlock
2027
$2.3b 4.62%
Unlock
2028
$2.5b 8.58%
Unlock
2029
$2.6b 3.99%
Unlock

8 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2025. The average ICU Medical, Inc. EBITDA estimate is

$394m
Unlock
. This is
202.47% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$425m 226.29%
Unlock
, the lowest is
$373m 186.49%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $104m 59.64%
2025
$394m 279.19%
Unlock
2026
$444m 12.58%
Unlock
2027
$491m 10.59%
Unlock
2028
$411m 16.18%
Unlock
2029
$460m 11.90%
Unlock

EBITDA Margin

2024 4.36% 51.41%
2025
17.63% 303.96%
Unlock
2026
20.11% 14.07%
Unlock
2027
21.26% 5.72%
Unlock
2028
16.41% 22.81%
Unlock
2029
17.66% 7.62%
Unlock

9 ICU Medical, Inc. Analysts have issued a net profit forecast 2025. The average ICU Medical, Inc. net profit estimate is

$176m
Unlock
. This is
576.32% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$182m 593.23%
Unlock
, the lowest is
$166m 549.23%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-118m 296.80%
2025
$176m 249.55%
Unlock
2026
$204m 15.70%
Unlock
2027
$239m 17.46%
Unlock
2028
$313m 30.67%
Unlock
2029
$339m 8.54%
Unlock

Net Margin

2024 -4.94% 276.32%
2025
7.87% 259.29%
Unlock
2026
9.23% 17.28%
Unlock
2027
10.36% 12.24%
Unlock
2028
12.47% 20.37%
Unlock
2029
13.01% 4.33%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -4.83 7.13
292.68% 247.62%
P/E 18.41
EV/Sales 1.92

9 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is

$7.13
Unlock
. This is
578.52% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$7.38 595.30%
Unlock
, the lowest is
$6.72 551.01%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-4.83 292.68%
2025
$7.13 247.62%
Unlock
2026
$8.25 15.71%
Unlock
2027
$9.69 17.45%
Unlock
2028
$12.66 30.65%
Unlock
2029
$13.74 8.53%
Unlock

P/E ratio

Current -88.08 55.56%
2025
18.41 120.90%
Unlock
2026
15.91 13.58%
Unlock
2027
13.55 14.83%
Unlock
2028
10.37 23.47%
Unlock
2029
9.55 7.91%
Unlock

Based on analysts' sales estimates for 2025, the ICU Medical, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.80 22.41%
2025
1.92 6.39%
Unlock
2026
1.94 1.32%
Unlock
2027
1.85 4.42%
Unlock
2028
1.71 7.90%
Unlock
2029
1.64 3.83%
Unlock

P/S ratio

Current 1.37 22.08%
2025
1.45 6.11%
Unlock
2026
1.47 1.31%
Unlock
2027
1.40 4.41%
Unlock
2028
1.29 7.90%
Unlock
2029
1.24 3.84%
Unlock

Current ICU Medical, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked Aug 15 2025
Raymond James
Locked
Locked
Locked Aug 08 2025
Raymond James
Locked
Locked
Locked May 09 2025
Keybanc
Locked
Locked
Locked Apr 21 2025
Needham
Locked
Locked
Locked Apr 08 2025
Jefferies
Locked
Locked
Locked Dec 11 2024
Keybanc
Locked
Locked
Locked Nov 13 2024
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
Aug 15 2025
Locked
Raymond James:
Locked
Locked
Aug 08 2025
Locked
Raymond James:
Locked
Locked
May 09 2025
Locked
Keybanc:
Locked
Locked
Apr 21 2025
Locked
Needham:
Locked
Locked
Apr 08 2025
Locked
Jefferies:
Locked
Locked
Dec 11 2024
Locked
Keybanc:
Locked
Locked
Nov 13 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today